Barrington Research Forecasts Reduced Earnings for Cinemark

Key Points

• Analysts at Barrington Research have reduced their Q1 2026 earnings per share estimate for Cinemark to ($0.19), downgrading from a previous estimate of ($0.18).
• Cinemark reported a quarterly earnings miss with $0.63 EPS, falling short of the consensus estimate of $0.78 by $0.15.
• Despite the lowered earnings estimates, Barrington maintains an "Outperform" rating on Cinemark with a price target of $36.00.

Cinemark Holdings Inc (NYSE:CNK - Free Report) - Analysts at Barrington Research lowered their Q1 2026 earnings per share estimates for Cinemark in a research report issued to clients and investors on Thursday, October 16th. Barrington Research analyst P. Sholl now expects that the company will post earnings per share of ($0.19) for the quarter, down from their previous estimate of ($0.18). Barrington Research currently has a "Outperform" rating and a $36.00 price objective on the stock. The consensus estimate for Cinemark's current full-year earnings is $1.93 per share. Barrington Research also issued estimates for Cinemark's Q3 2026 earnings at $0.67 EPS.

Cinemark (NYSE:CNK - Get Free Report) last issued its quarterly earnings data on Friday, August 1st. The company reported $0.63 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.78 by ($0.15). Cinemark had a return on equity of 59.16% and a net margin of 9.13%.The firm had revenue of $940.50 million for the quarter, compared to analysts' expectations of $942.14 million. During the same period in the previous year, the business posted $0.32 EPS. The business's revenue for the quarter was up 28.1% compared to the same quarter last year.

A number of other equities analysts have also issued reports on the company. Wedbush raised Cinemark from a "neutral" rating to an "outperform" rating and raised their price target for the stock from $32.00 to $37.00 in a report on Friday, July 11th. Wall Street Zen raised Cinemark from a "sell" rating to a "hold" rating in a report on Sunday, August 10th. Wells Fargo & Company reissued an "overweight" rating and set a $33.00 price target (down previously from $36.00) on shares of Cinemark in a report on Monday, August 4th. Roth Capital lowered their price target on Cinemark from $36.00 to $34.00 and set a "buy" rating on the stock in a report on Monday, August 4th. Finally, JPMorgan Chase & Co. raised their price target on Cinemark from $37.00 to $38.00 and gave the stock an "overweight" rating in a report on Thursday, October 9th. Nine equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, Cinemark has a consensus rating of "Moderate Buy" and a consensus price target of $35.40.

Cinemark Stock Performance

NYSE CNK opened at $26.45 on Monday. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 4.32. Cinemark has a 52-week low of $23.12 and a 52-week high of $36.28. The business's 50-day moving average price is $26.82 and its 200 day moving average price is $28.79. The firm has a market cap of $3.04 billion, a P/E ratio of 14.45, a P/E/G ratio of 1.87 and a beta of 1.75.

Cinemark Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 10th. Investors of record on Wednesday, August 27th were given a $0.08 dividend. The ex-dividend date was Wednesday, August 27th. This represents a $0.32 dividend on an annualized basis and a yield of 1.2%. Cinemark's dividend payout ratio (DPR) is presently 17.49%.

Insider Buying and Selling

In related news, EVP Melissa Thomas sold 7,200 shares of the firm's stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $25.17, for a total value of $181,224.00. Following the completion of the sale, the executive vice president owned 203,768 shares in the company, valued at $5,128,840.56. This trade represents a 3.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 2.30% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Cinemark

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Wellington Management Group LLP lifted its position in shares of Cinemark by 12.9% during the 1st quarter. Wellington Management Group LLP now owns 9,346,856 shares of the company's stock valued at $232,643,000 after acquiring an additional 1,066,225 shares during the period. Marshall Wace LLP lifted its position in shares of Cinemark by 758.9% during the 2nd quarter. Marshall Wace LLP now owns 4,497,305 shares of the company's stock valued at $135,729,000 after acquiring an additional 3,973,689 shares during the period. Assenagon Asset Management S.A. lifted its position in shares of Cinemark by 106.9% during the 2nd quarter. Assenagon Asset Management S.A. now owns 2,589,372 shares of the company's stock valued at $78,147,000 after acquiring an additional 1,338,153 shares during the period. Squarepoint Ops LLC lifted its position in shares of Cinemark by 119.9% during the 2nd quarter. Squarepoint Ops LLC now owns 2,180,513 shares of the company's stock valued at $65,808,000 after acquiring an additional 1,188,709 shares during the period. Finally, Qube Research & Technologies Ltd lifted its position in shares of Cinemark by 18.7% during the 2nd quarter. Qube Research & Technologies Ltd now owns 2,012,913 shares of the company's stock valued at $60,750,000 after acquiring an additional 316,476 shares during the period.

About Cinemark

Cinemark Holdings, Inc, together with its subsidiaries, engages in the motion picture exhibition business. As of February 16, 2024, it operated 501 theatres with 5,719 screens in 42 states and 13 countries in South and Central America. Cinemark Holdings, Inc was founded in 1984 and is headquartered in Plano, Texas.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.